Clinical Trials Directory

Trials / Completed

CompletedNCT01682655

Genetic Variant in Apolipoprotein C3 Gene and Fatty Liver in Obese Children

The Influence of Apolipoprotein C3 Variants on Liver Steatosis and Serum Liver Enzyme Values in Obese Children

Status
Completed
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
Far Eastern Memorial Hospital · Academic / Other
Sex
All
Age
6 Years – 18 Years
Healthy volunteers
Not accepted

Summary

In the past decades, obesity in children is much more prevalent in the world. Given the increasing prevalence of pediatric obesity worldwide, fatty liver incidence is on the rise. Genetic variant in apolipoprotein C3 (APOC3) gene is associated with increased liver fat content in adults. The aim of this study is to find out whether APOC3 single nucleotide polymorphism (SNP) influence fatty liver in obese children and adolescent.

Detailed description

The primary aim of this study is to assess the associations between to investigate the association of rs2854117 C \> T and rs2854116 T \> C SNPs of the APOC3 gene with liver steatosis, as measured by liver ultrasound. As a secondary aim, the investigators will examine the associations between APOC3 rs2854117 C \> T and rs2854116 T \> C SNPs and serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels. In addition, the investigators will further analyze the association with other biomarkers, such as body mass index, adiponectin and insulin resistance.

Conditions

Timeline

Start date
2012-07-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2012-09-11
Last updated
2015-03-17

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01682655. Inclusion in this directory is not an endorsement.